Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Idelalisib preparation method offers significant cost reduction and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking high-purity APIs.
Patent CN113583088A details novel cyclic peptide synthesis targeting STRN3 for gastric cancer, offering improved stability and cell permeability for pharmaceutical manufacturing.
Patent CN106854182B reveals a high-yield, one-pot synthesis for 2,5-dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine, offering significant cost reduction in API manufacturing.
Novel synthesis of 5,6-hydroxyl substituted brazilin analog via Prins/Friedel-Crafts reaction. Offers cost-effective route for bladder cancer drug intermediates.
Patent CN111302997A reveals a streamlined one-pot method for Raatinib intermediates, offering significant cost and waste reduction for API manufacturing.
Novel synthesis of Abiraterone Acetate via CN107176965A patent. Cost-effective route using pregnadienolone acetate for reliable pharmaceutical intermediate supply chain.
Patent CN106243018B reveals nickel-catalyzed route for PIM447 intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Novel mild method for Imatinib production avoiding toxic reagents. High yield, scalable process for pharmaceutical intermediates ensuring supply chain stability.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Novel Boc-protection strategy for high-purity Raltitrexed intermediate. Reduces side reactions, improves yield, ensures supply chain stability for pharma manufacturing.
Discover the novel Canertinib synthesis via CN103242244A. A streamlined, cost-effective route for high-purity pharmaceutical intermediates suitable for industrial scale-up.
Novel patent CN105218463B details eco-friendly Gefitinib synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis route for progesterone pyrazinamide compounds targeting prostate cancer. Efficient convergent strategy reduces costs and improves supply chain reliability for API intermediates.
Patent CN102603718A details a high-yield Cediranib synthesis. Offers cost reduction in pharmaceutical manufacturing and scalable routes for reliable API intermediate supply.
Patent CN1413203A reveals a high-yield route for phthalazinones, offering safer processing and significant cost reduction for pharmaceutical manufacturing.
Advanced synthesis of pyrrolotriazine intermediates for kinase inhibitors. Optimized routes for c-Met targeting drugs with improved scalability and purity.
Patent CN103242215A details a safer transfer hydrogenation route for Lenalidomide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Patent CN1563014A details novel Garcinia acid derivatives with enhanced stability and solubility for oncology. Discover cost-effective manufacturing strategies for these high-purity pharmaceutical intermediates.
Patent CN102199146A details a high-yield catalytic transfer hydrogenation for Imatinib intermediates, offering superior purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN103242216A reveals a high-yield synthesis of N-Boc-hexahydro-5-oxo-cyclopenta(C)pyrrole using tetrahydrophthalimide, offering significant cost reduction and supply reliability for pharmaceutical intermediates.